loading page

Large tricuspid valve thrombus complicating COVID-19 pneumonia
  • Yasser Kamal,
  • Shady E. Al-Elwany,
  • Mostafa M. ELsayed
Yasser Kamal
Minia University Faculty of Medicine
Author Profile
Shady E. Al-Elwany
Minia University Faculty of Medicine
Author Profile
Mostafa M. ELsayed
Minia University Faculty of Medicine
Author Profile

Abstract

Background: Hemostatic disturbances with coronavirus disease 2019 (COVID-19) can predispose to tricuspid and right heart thrombi in very rare instances. Aim: We describe a 29-year-old female patient without previous cause of thrombosis who developed large tricuspid valve thrombus (TVT) and moderate-to-severe tricuspid regurgitation (TR) during the course of COVID-19 infection. Materials and methods: Persistant fever and tachycardia with thrombocytopenia and high D-dimer increased the index of suspicion. The diagnosis was made by bedside transthoracic echocardiography (TTE) and cardiac magnetic resonance (CMR). Surgery was performed for thrombectomy and tricuspid valve replacement with a tissue valve. Discussion and conclusion: Detection of TVT in COVID-19 patients on the basis of high index of suspicion, bedside TTE and non-invasive CMR helps early surgical treatment and subsequent reduction of mortality and hospital stay.
27 Jun 2022Submitted to Journal of Cardiac Surgery
27 Jun 2022Assigned to Editor
27 Jun 2022Submission Checks Completed
27 Jun 2022Reviewer(s) Assigned
27 Jun 2022Review(s) Completed, Editorial Evaluation Pending
28 Jun 2022Editorial Decision: Accept
16 Jul 2022Published in Journal of Cardiac Surgery. 10.1111/jocs.16761